Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 12 Mar 2026 for Stoke Therapeutics, Inc., €28k. Read the official filing
Filing timeline
BuySaleArthur Tzianabos
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Arthur Tzianabos: trading record in brief
Filings by Arthur Tzianabos span 3 companies, the busiest being Q32 Bio Inc., Stoke Therapeutics, Inc. and Akouos, Inc. In total, 8 filings cover trades dated from 1 January 2022 to 10 March 2026.
No open-market purchase appears, only 1 sale worth €14k. Outside the open market, there are 6 option exercises.
The latest filing, published on 12 March 2026, reports an option exercise of €28k in Stoke Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Arthur Tzianabos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
3,955 shares@ US$8.3330.5% of flowCommon StockSEC:0001586226-26-000002:0
1,095 sharesCommon StockSEC:0000950170-24-096986:0
14,280 sharesCommon StockSEC:0000950170-24-015944:0
31,739 shares@ US$2.19100.0% of flowCommon StockSEC:0001415889-24-003897:0
10,616 shares@ US$1.3905100.0% of flowCommon StockSEC:0000899243-23-001574:0
13,860 sharesCommon StockSEC:0000899243-23-000632:0
26,930 sharesCommon StockSEC:0001104659-22-124141:0
13,860 sharesCommon StockSEC:0000899243-22-001743:0
8 of 8 declarations
